retatrutide 2024 Retatrutide: FDA approval time, trial results & weight loss Substack Series 3 of 6:

And remember to breathe

Pregnancy and breastfeeding - GLP-1 medications are not recommended during pregnancy or breastfeeding

Overlapping Metabolic Pathways Where These Peptides Converge While MOTS-C and Retatrutide operate through different primary mechanisms, they converge on several metabolic outcomes that reinforce each other

Before steady state, each weekly injection adds to the accumulating pool but you have not yet reached the plateau where effects are maximized

Oral and injectable GLP-1 medications like semaglutide are available in different forms and doses

Consider timing to avoid major food-centered celebrations during hardest weeks